Gene397
ARHGDIB: Rho GDP dissociation inhibitor beta
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. ARHGDIB: Rho GDP dissociation inhibitor beta. Genes, record 397. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/397
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P52566 | Rho GDP-dissociation inhibitor 2 | 201 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents157
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 61661 | P52566 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61663 | P52566 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 61664 | P52566 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 718 | P52566 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 718 | P52566 | Espacenet |
| US 20250277786 A1 | 2025-09-04 | 40 | P52566 | Espacenet |
| US 12332243 B2 | 2025-06-17 | 3 | P52566 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 718 | P52566 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 730 | P52566 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 730 | P52566 | Espacenet |
NIH grants589
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ARHGDIB papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 5 | 2025 |
| ZIACP010121 | Molecular Epidemiology Studies of Occupational and Environmental Exposures | 4 | 2025 |
| IK6BX005383 | BLRD Research Career Scientist Award Application | 3 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 3 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 3 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 2 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
Source NIH's project files
Papers1,070
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Autoimmune disease influence on polycystic ovary syndrome: Insights from Mendelian randomization and multi-omics analysis. | Adv Clin Exp Med | 2026 | 42803088 | PubTator, text mining | PubMed |
| Tree-Based Classification of COVID-19 Using NanoString Whole-Blood Immune-Response Profiles: Comparison of Full-Dataset and LOOCV-Embedded Feature Selection. | Viruses | 2026 | 42797840 | PubTator, text mining | PubMed |
| Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. | J Inflamm Res | 2026 | 41798638 | PubTator, text mining | PubMed |
| Establishment of a novel gene panel for prognosis assessment in patients with lower grade glioma. | Medicine (Baltimore) | 2026 | 41760070 | PubTator, text mining | PubMed |
| Proteostasis sustains T cell differentiation potential and tumor-infiltrating lymphocyte function. | bioRxiv | 2026 | 41727040 | PubTator, text mining | PubMed |
| Assessing reference ranges for non-HLA antibodies: Comparative analysis of blood donors and kidney transplant candidates. | Transpl Immunol | 2026 | 41692072 | PubTator, text mining | PubMed |
| The Presence of Non-HLA Antibody With DSA Is Associated With Moderate to Severe T Cell-Mediated Rejection in Liver Transplant Recipients. | Clin Transplant | 2026 | 41691619 | PubTator, text mining | PubMed |
| Delactylation of the tumor suppressor ARHGDIB drives metastasis and chemoresistance in bladder cancer. | Cell Rep | 2026 | 41637189 | PubTator, text mining | PubMed |
| RETRACTION: Diallyl Disulfide Downregulating RhoGDI2 Induces Differentiation and Inhibit Invasion Via the Rac1/Pak1/LIMK1 Pathway in Human Leukemia HL-60 Cells. | Environ Toxicol | 2026 | 41510596 | PubTator, text mining | PubMed |
| Identifying potential therapeutic targets in periodontitis: a multi-omics approach integrating bulk and single-cell RNA sequencing with Mendelian randomization. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 40921808 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/397
GET https://conductscience.org/api/genes/v1/397/patents?page=2